Timing of Antiretroviral Therapy for HIV in the Setting of TB Treatment
The convergent human immunodeficiency virus (HIV) and tuberculosis (TB) pandemics continue to collectively exact significant morbidity and mortality worldwide. Highly active antiretroviral therapy (HAART) has been a critical component in combating the scourge of these two conditions as both a preem...
Saved in:
Main Authors: | Damani A. Piggott, Petros C. Karakousis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2011/103917 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings
by: Kevin Peterson, et al.
Published: (2011-01-01) -
Modeling TB-HIV Syndemic and Treatment
by: Cristiana J. Silva, et al.
Published: (2014-01-01) -
Treatment of HIV-1 Infection with Combination Therapy: Antiretroviral Agents and Biological Response Modifiers
by: Steven M Schnittman
Published: (1994-01-01) -
Modelling In Vivo HIV Dynamics under Combined Antiretroviral Treatment
by: B. Mobisa, et al.
Published: (2018-01-01) -
Timing of recurrence after treatment of pulmonary TB
by: C.T. Mithunage, et al.
Published: (2024-10-01)